Compare Intuitive Surgical, Inc. (ISRG) vs Levi Strauss & Co. (LEVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Levi Strauss & Co. — how do they compare? Intuitive Surgical, Inc. trades at $424.03 (market cap $146.76B), while Levi Strauss & Co. trades at $18.54 (market cap $7.31B). The key difference: Intuitive Surgical, Inc. is far larger — about 20.1× Levi Strauss & Co.'s market cap, and Levi Strauss & Co. pays a 3.36% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Levi Strauss & Co. for 70 Days on average.
| ISRG | LEVI | |
|---|---|---|
Market Cap | $146.76B | $7.31B |
Volume | 2,529,814 | 13,683,095 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $25.53 |
52-Week Low | $332.02 | $17.92 |
Typical Hold Time | 84 Days | 70 Days |
Enterprise Value | $141.54B | $8.86B |
Dividend Yield | — | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $414.52, up 2.41% today, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with revenue growth from $6.2B in 2022 to $10.1B in 2025 and net income margin expanding to 28.45%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast.
ISRG maintains a dominant position in robotic surgery with expanding international growth, though valuation multiples remain elevated with a P/E of 47.64. Analyst consensus is strongly bullish with a $480.78 price target representing 16% upside potential. Key risks include competitive pressures and international market volatility, particularly in China.
Levi Strauss (LEVI) trades at $19.51, down 4.97% on the day, with a bearish technical signal despite strong fundamentals. The company demonstrates robust profitability with 62.81% gross margins and 8.83% net income margin, supported by four consecutive quarterly earnings beats. Analyst consensus remains strongly bullish with a $29 price target representing 49% upside potential. Recent developments include the appointment of a new CFO and continued momentum in denim demand driving revenue growth.
The stock presents a compelling value opportunity with attractive valuation multiples (P/E 12.53, P/S 1.12) and strong cash flow generation. However, near-term technical weakness and recent cybersecurity concerns require monitoring. The company's direct-to-consumer strategy and international expansion provide growth catalysts, though execution risks and market volatility remain considerations for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →
